Literature DB >> 2158806

Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983.

C K Connolly1, W G Jones, J Thorogood, C Head, M F Muers.   

Abstract

We studied all cases presenting during life with carcinoma of the bronchus and registered at the Yorkshire Regional Cancer Registry 1976-1983. During this period fibreoptic bronchoscopy became more widely available in the region, and multiple drug chemotherapy became first line treatment for small cell carcinoma. Although there was little change in the overall incidence of lung cancer during the study period, the proportion of females increased by 4.8% and the mean age at presentation rose by 2.3 years. The histological confirmation rate rose by 29% from 45% to 58%. The proportion of patients with small cell carcinoma treated by chemotherapy increased from 17% to 39%. With this exception therapeutic intervention rates were unaltered. The prognosis of patients with small cell carcinoma treated by chemotherapy improved, particularly so for those less than 60 years. There was a consistent trend for an overall improvement in survival in other groups, and this was significant for those aged 70 and over where it appeared to be related to more appropriate management of squamous cell carcinoma. We conclude from this regional study that increased diagnostic activity in District General Hospitals has allowed an improvement in prognosis both for patients with small cell carcinoma treated by chemotherapy, and in patients over 70 with non-small cell cancer. These trends can be expected to continue over the next few years.

Entities:  

Mesh:

Year:  1990        PMID: 2158806      PMCID: PMC1971353          DOI: 10.1038/bjc.1990.130

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Hazards of bronchoscopy.

Authors:  I W Grant
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-02

2.  Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.

Authors:  M D Vincent; S E Ashley; I E Smith
Journal:  Eur J Cancer Clin Oncol       Date:  1987-11

3.  Fibreoptic bronchoscopy in the elderly: 4 years' experience.

Authors:  A J Knox; B H Mascie-Taylor; R L Page
Journal:  Br J Dis Chest       Date:  1988-07

4.  Postal survey of bronchoscopic practice by physicians in the United Kingdom.

Authors:  F G Simpson; A G Arnold; A Purvis; P W Belfield; M F Muers; N J Cooke
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

5.  Alkylating agents in bronchogenic carcinoma.

Authors:  R A Green; E Humphrey; H Close; M E Patno
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

6.  Trends in lung cancer mortality.

Authors:  D Coggon; E D Acheson
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

7.  Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.

Authors:  R L Souhami; D M Geddes; S G Spiro; P G Harper; J S Tobias; B S Mantell; F Fearon; I Bradbury
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-02

8.  Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly.

Authors:  J T Macfarlane; A Storr; M J Wart; W H Smith
Journal:  Age Ageing       Date:  1981-05       Impact factor: 10.668

9.  Facilities for the diagnosis of respiratory disease in the UK. A survey of 276 thoracic physicians. Report of a working party of the British Thoracic Society's Regional Representatives Committee.

Authors:  M F Muers; A G Chappell; M Farebrother; S C Farrow; B D Harrison; G Laszlo
Journal:  J R Coll Physicians Lond       Date:  1988-07
  9 in total
  21 in total

Review 1.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 2.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

3.  Age and the treatment of lung cancer.

Authors:  J S Brown; D Eraut; C Trask; A G Davison
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

4.  Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group.

Authors:  M F Muers; C E Round
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

5.  BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee.

Authors: 
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  Management of lung cancer in South East Scotland.

Authors:  R J Fergusson; A Gregor; R Dodds; G Kerr
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 7.  Management of lung cancer.

Authors:  M F Muers; R A Haward
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

8.  Collecting data on cancer.

Authors:  I Basnett; A M Pollock; M Gill
Journal:  BMJ       Date:  1994-03-19

9.  Improving surgical resection rate in lung cancer.

Authors:  C Laroche; F Wells; R Coulden; S Stewart; M Goddard; E Lowry; A Price; D Gilligan
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

10.  Lung cancer patterns of care in south western Sydney, Australia.

Authors:  S K Vinod; G P Delaney; A E Bauman; M B Barton
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.